Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PHASE II SAFETY AND EFFICACY STUDY OF CG0070 ONCOLYTIC VECTOR REGIMEN IN PATIENTS WITH HIGH GRADE NON-MUSCLE INVASIVE BLADDER CARCINOMA DISEASE (NMIBC) WHO HAVE FAILED BCG AND REFUSED CYSTECTOMY

Next Previous
Trial Profile

PHASE II SAFETY AND EFFICACY STUDY OF CG0070 ONCOLYTIC VECTOR REGIMEN IN PATIENTS WITH HIGH GRADE NON-MUSCLE INVASIVE BLADDER CARCINOMA DISEASE (NMIBC) WHO HAVE FAILED BCG AND REFUSED CYSTECTOMY

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cretostimogene grenadenorepvec (Primary)
  • Indications Bladder cancer; Carcinoma; Urogenital cancer
  • Focus Therapeutic Use
  • Acronyms exBOND
  • Sponsors CG Oncolgy

Most Recent Events

  • 25 Mar 2020 According to a Cold Genesys media release, Cold Genesys changed its name to CG Oncology.
  • 30 Jan 2019 Status changed from completed to withdrawn prior to enrolment.
  • 27 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top